RecruitingNCT05620095

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions

Multicenter Registry for pAclitaxel- Coated Balloon angioplasTy in Infrapopliteal Arterial Lesions (the ACT Study)

Sponsor

Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

Enrollment

1,000 participants

Start Date

Dec 1, 2020

Study Type

OBSERVATIONAL

Conditions

Chronic Limb Threatening Ischemia Peripheral Artery Disease Arteriosclerosis

Summary

This study is a multicenter observational study designed to evaluate the the effectiveness and safety of drug-coated balloon (DCB) angioplasty for below the knee arterial lesions in patients critical with Limb Threatening Ischemia (CLTI).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called drug-coated balloon for people with arteriosclerosis, chronic limb threatening ischemia, and other related conditions. The study is currently recruiting participants at 10 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEdrug-coated balloon

To evaluate the effectiveness and safety of drug-coated balloon angioplasty for infrapopliteal artery lesions in patients with CLTI.

Locations(10)

Xuanwu Hospital Capital Medical University

Beijing, Beijing Municipality, China

Zibo Feng

Wuhan, Hubei, China

the second Affiliated Hospital of Medical College of Suzhou University

Suzhou, Jiangsu, China

Qingdao Haici hospital affiliated to Qingdao University

Qingdao, Shandong, China

Huashan Hospital, Fudan University

Shanghai, Shanghai Municipality, China

Renji Hospital of Shanghai Jiaotong University

Shanghai, Shanghai Municipality, China

Zhongshan Hospital of Fudan University

Shanghai, Shanghai Municipality, China

Hospital of Chengdu University of Traditional Chinese Medicine

Chengdu, Sichuan, China

Hangzhou First People's hospital of Medical College of Zhejiang University

Hangzhou, Zhejiang, China

the First Affiliated hospital of Medicine College of Zhejiang University

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05620095

Related Trials

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT072582902 locations

Colchicine in Chronic Limb-Threatening Ischemia

NCT075363735 locations

A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

NCT0728657813 locations

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

NCT072832891 location

Vessel Recoil in Specific CLTI Populations

NCT074656271 location